ClinicalTrials.gov
ClinicalTrials.gov Menu

Eltrombopag Olamine in Treating Patients With Relapsed/Refractory Acute Myeloid Leukemia

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01550185
Recruitment Status : Terminated (Sponsor wanted study rewritten)
First Posted : March 9, 2012
Last Update Posted : April 6, 2016
Sponsor:
Collaborators:
National Cancer Institute (NCI)
GlaxoSmithKline
Information provided by (Responsible Party):
Roswell Park Cancer Institute

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Terminated
  Actual Primary Completion Date : December 2014
  Actual Study Completion Date : December 2014